University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT05226078
Cancer-related fatigue (CRF) and insomnia are prevalent among cancer patients and have been linked to de-creases in quality of life and poorer overall survivorship. Currently, the mechanisms underlying CRF are not well understood, which has led to treatments that are only moderately effective. In addition, when compared to CBT-I in the general population, the treatment outcomes in CBT-I with cancer patients are subpar and, as such, this study will evaluate whether dose of CBT-I is effective in ameliorating CRF.
This study is active but is not currently recruiting participants.
25 year–85 year
Female
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
Subjects will be randomized into one of four groups, four, eight, ten or twelve sessions. Sessions will be con-ducted weekly by Telehealth and will be modified based on the duration of treatment but all will include the following, evaluation and orientation; data acquisition and delivery of sleep restriction therapy & stimulus control instructions; review of sleep hygiene; cognitive therapy [decatastrophization]; managing non-adherence and relapse prevention), and, finally, the final sessions will be largely focused on time-in-bed titration. Treatment will be conducted by a master therapist via a HIPAA compliant video link.
All CBT-I related data will be obtained via dedicated internet websites built with RedCap, where subjects will be asked to complete weekly and monthly questionnaires. One website will be for use by subjects. One website will be for use by the therapist. The patient and therapist website will have a landing page (password entry), a login page, and an activities page (what questionnaires are due when). For an example of such a website, please see our pilot study, https://redcap.med.upenn.edu/surveys/?s=RXLLA7C4KJ (access using password "sleepstudy"). The patient website will contain daily sleep diaries, weekly severity measures of insomnia (ISI), sleepiness (ESS), fatigue (PROMIS 7a, Brief Fatigue Inventory, and FACIT-F), depression (PHQ-9), anxiety (GAD-7), a medical symptoms checklist.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cognitive behavioral treatment of insomnia
Other names: CBT-I
Time frame: Baseline to End of Treatment (Up to 12 weeks)
Proportion of screened eligible subjects who: complete a screener; enroll; and accept randomization.
Time frame: Baseline to End of Treatment (Up to 12 weeks)
Average adherence to Sleep Restriction Therapy (SRT) and Stimulus Control Therapy (SCT) [overall and by week] as measured by deviations between prescribed and actual times (from sleep diaries), overall and by group.
Time frame: End of Treatment
Average Insomnia Treatment Acceptability Scale (ITAS) scores, overall and by group.
Total score for each subscale is the average of the 8 items, with higher scores indicating greater willingness to utilize the treatment.
Time frame: Baseline to End of Treatment (Up to 12 weeks)
Percent of subjects who complete the study, overall and by group.
Abramson Cancer Center at Penn Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02660385
Anxiety, Anxiety Disorders
West Haven, Connecticut, United States
View Trial DetailsNCT02515006
Cancer, Chronic Insomnia
Ahmedabad, Gujarat, India
View Trial DetailsNCT04024787
Chronic Insomnia, Dyssomnias
Montreal, Quebec, Canada
View Trial DetailsNCT06073990
Behavior, Chronic Insomnia
Tainan, Taiwan
View Trial Details